Workflow
What Does Wall Street Think About Corcept Therapeutics (CORT)?

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best stocks to buy with over 50% upside potential. Canaccord Genuity analyst Edward Nash maintained a Buy rating on Corcept Therapeutics Incorporated (NASDAQ:CORT) on October 21, setting a 140pricetarget.WhyCorceptTherapeuticsIncorporated(CORT)CrashedOnMondaySimilarly,H.C.WainwrightanalystSwayampakulaRamakanthalsomaintainedaBuyratingonCorceptTherapeuticsIncorporated(NASDAQ:CORT)onOctober20,andseta140 price target. Why Corcept Therapeutics Incorporated (CORT) Crashed On Monday Similarly, H.C. Wainwright analyst Swayampakula Ramakanth also maintained a Buy rating on Corcept Therapeutics Incorporated (NASDAQ:CORT) on October 20, and set a 145 price ta ...